Phase I Study of pCAR-19B in the Treatment of Adult CD19-positive Relapsed/Refractory B-ALL

Clinical trial NCT04888442 · UNKNOWN

Trial details

NCT number: NCT04888442
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, in Relapse Refractory Acute Lymphoblastic Leukemia

Start date: 2020-10-26
Primary completion: 2022-01-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.